Month 12 Outcomes after Treatment Change at Month 6 among Poor Responders to Aflibercept or Bevacizumab in Eyes with Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study
Michael S. Ip, Neal L. Oden, Ingrid U. Scott, Paul C. Vanveldhuisen, Barbara A. Blodi, Thomas Ghuman, Carl W. Baker
Dive into the research topics of 'Month 12 Outcomes after Treatment Change at Month 6 among Poor Responders to Aflibercept or Bevacizumab in Eyes with Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study'. Together they form a unique fingerprint.